Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease

Progress in Neurobiology

Volumn 147, Issue , 2016, Pages 1-19

  Jiang, Tianfang ^a   Sun, Qian ^a   Chen, Shengdi ^a,b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antioxidative agent; Mitochondria; NADPH oxidase; Neurodegenerative disease; Oxidative stress; Signaling pathway

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ANTIOXIDANT; DJ 1 PROTEIN; FREE RADICAL; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROPROTECTIVE AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; TAU PROTEIN;

ALZHEIMER DISEASE; HUMAN; NERVE CELL LESION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THERAPY EFFECT; DRUG EFFECTS; METABOLISM; PHYSIOLOGY;

ALZHEIMER DISEASE; ANTIOXIDANTS; HUMANS; OXIDATIVE STRESS; PARKINSON DISEASE;

EID: 84996843203     PISSN: 03010082     EISSN: 18735118     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2016.07.005     Document Type: Review

References (236)

1. Abdul, H.M., Butterfield, D.A., Involvement of PI3 K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by co-treatment of acetyl-L-carnitine and α-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. Free Radic. Biol. Med., 42, 2007, 371.
2. Ali, G.-C., Guerchet, M., Wu, Y.-T., Prince, M., Prina, M., Wimo, A., World Alzheimer Report 2015: The Global Impact of Dementia., 2015, Alzheimer's Disease Internationa, London.
3. Alonso, A., Zaidi, T., Novak, M., Grundke-Iqbal, I., Iqbal, K., Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 6923–6928.
4. Anand, R., Gill, K.D., Mahdi, A.A., Therapeutics of Alzheimer's disease: past, present and future. Neuropharmacology 76:Pt A (2014), 27–50.
5. Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T.M., Thomas, B., Ko, H.S., Sasaki, M., Ischiropoulos, H., Przedborski, S., Dawson, T.M., Dawson, V.L., DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 14807–14812.
6. Angeles, D.C., Gan, B.H., Onstead, L., Zhao, Y., Lim, K.L., Dachsel, J., Melrose, H., Farrer, M., Wszolek, Z.K., Dickson, D.W., Tan, E.K., Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Hum. Mutat. 32 (2011), 1390–1397.
7. Ariga, H., Takahashi-Niki, K., Kato, I., Maita, H., Niki, T., Iguchi-Ariga, S.M., Neuroprotective function of DJ-1 in Parkinson's disease. Oxid. Med. Cell Longev., 2013, 2013, 683920.
8. Armstrong, R.A., Spatial patterns of beta-amyloid (Abeta) deposits in familial and sporadic Alzheimer's disease. Folia Neuropathol. 49 (2011), 153–161.
9. Armstrong, R.A., Laminar distribution of beta-amyloid (Abeta) peptide deposits in the frontal lobe in familial and sporadic Alzheimer's disease. Folia Neuropathol. 53 (2015), 15–23.
10. Barabash, A., Marcos, A., Ancin, I., Vazquez-Alvarez, B., de Ugarte, C., Gil, P., Fernandez, C., Encinas, M., Lopez-Ibor, J.J., Cabranes, J.A., APOE: ACT and CHRNA7 genes in the conversion from amnestic mild cognitive impairment to Alzheimer's disease. Neurobiol. Aging 30 (2009), 1254–1264.
11. Barnham, K.J., Masters, C.L., Bush, A.I., Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3 (2004), 205–214.
12. Baulac, S., Lu, H., Strahle, J., Yang, T., Goldberg, M.S., Shen, J., Schlossmacher, M.G., Lemere, C.A., Lu, Q., Xia, W., Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains. Mol. Neurodegener., 4, 2009, 12.
13. Baum, L., Lam, C.W., Cheung, S.K., Kwok, T., Lui, V., Tsoh, J., Lam, L., Leung, V., Hui, E., Ng, C., Woo, J., Chiu, H.F., Goggins, W.B., Zee, B.C., Cheng, K.F., Fong, C.Y., Wong, A., Mok, H., Chow, M.S., Ho, P.C., Ip, S.P., Ho, C.S., Yu, X.W., Lai, C.Y., Chan, M.H., Szeto, S., Chan, I.H., Mok, V., Six-month randomized placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. J. Clin. Psychopharmacol. 28 (2008), 110–113.
14. Bedard, K., Krause, K.H., The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313.
15. Belluzzi, E., Bisaglia, M., Lazzarini, E., Tabares, L.C., Beltramini, M., Bubacco, L., Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease. PLoS One, 7, 2012, e38026.
16. Billia, F., Hauck, L., Grothe, D., Konecny, F., Rao, V., Kim, R.H., Mak, T.W., Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 6085–6090.
17. Bjelakovic, G., Nikolova, D., Gluud, L.L., Simonetti, R.G., Gluud, C., Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297 (2007), 842–857.
18. Blackinton, J., Lakshminarasimhan, M., Thomas, K.J., Ahmad, R., Greggio, E., Raza, A.S., Cookson, M.R., Wilson, M.A., Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1. J. Biol. Chem. 284 (2009), 6476–6485.
19. Bonifati, V., LRRK2 low-penetrance mutations (Gly2019Ser) and risk alleles (Gly2385Arg)-linking familial and sporadic Parkinson's disease. Neurochem. Res. 32 (2007), 1700–1708.
20. Brewer, G.J., Why vitamin E therapy fails for treatment of Alzheimer's disease. J. Alzheimers Dis. 19 (2010), 27–30.
21. Brieger, K., Schiavone, S., Miller, F.J. Jr., Krause, K.H., Reactive oxygen species: from health to disease. Swiss Med. Wkly., 142, 2012, w13659.
22. Bukhari, S.N., Jantan, I., Synthetic curcumin analogs as inhibitors of beta – amyloid peptide aggregation: potential therapeutic and diagnostic agents for alzheimer's disease. Mini Rev. Med. Chem. 15 (2015), 1110–1121.
23. Butterfield, D.A., Sultana, R., Methionine-35 of abeta(1–42): importance for oxidative stress in Alzheimer disease. J. Amino Acids, 2011, 2011, 198430.
24. Butterfield, D.A., Swomley, A.M., Sultana, R., Amyloid beta-peptide (1–42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid. Redox Signal. 19 (2013), 823–835.
25. Calne, D.B., Initiating treatment for idiopathic parkinsonism. Neurology 44 (1994), S19–22.
26. Canet-Aviles, R.M., Wilson, M.A., Miller, D.W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M.J., Ringe, D., Petsko, G.A., Cookson, M.R., The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 9103–9108.
27. Cardinali, D.P., Furio, A.M., Brusco, L.I., Clinical aspects of melatonin intervention in Alzheimer's disease progression. Curr. Neuropharmacol. 8 (2010), 218–227.
28. Carmo, M.R., Menezes, A.P., Nunes, A.C., Pliassova, A., Rolo, A.P., Palmeira, C.M., Cunha, R.A., Canas, P.M., Andrade, G.M., The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology 81 (2014), 142–152.
29. Castano, E.M., Prelli, F., Soto, C., Beavis, R., Matsubara, E., Shoji, M., Frangione, B., The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis: dutch type. Implications for the role of amyloid-beta 1–42 in Alzheimer's disease. J. Biol. Chem. 271 (1996), 32185–32191.
30. Cervellati, C., Cremonini, E., Bosi, C., Magon, S., Zurlo, A., Bergamini, C.M., Zuliani, G., Systemic oxidative stress in older patients with mild cognitive impairment or late onset Alzheimer's disease. Curr. Alzheimer Res. 10 (2013), 365–372.
31. Chaudhary, S., Behari, M., Dihana, M., Swaminath, P.V., Govindappa, S.T., Jayaram, S., Goyal, V., Maitra, A., Muthane, U.B., Juyal, R.C., Thelma, B.K., Parkin mutations in familial and sporadic Parkinson's disease among Indians. Parkinsonism Relat. Disord. 12 (2006), 239–245.
32. Cherra 3rd, S.J., Steer, E., Gusdon, A.M., Kiselyov, K., Chu, C.T., Mutant LRRK2 elicits calcium imbalance and depletion of dendritic mitochondria in neurons. Am. J. Pathol. 182 (2013), 474–484.
33. Chico, L., Simoncini, C., Lo Gerfo, A., Rocchi, A., Petrozzi, L., Carlesi, C., Volpi, L., Tognoni, G., Siciliano, G., Bonuccelli, U., Oxidative stress and APO E polymorphisms in Alzheimer's disease and in mild cognitive impairment. Free Radic. Res. 47 (2013), 569–576.
34. Cho, C.H., Kim, E.A., Kim, J., Choi, S.Y., Yang, S.J., Cho, S.W., N-Adamantyl-4-methylthiazol-2-amine suppresses amyloid beta-induced neuronal oxidative damage in cortical neurons. Free Radic. Res., 2016, 1–35.
35. Choi, J., Sullards, M.C., Olzmann, J.A., Rees, H.D., Weintraub, S.T., Bostwick, D.E., Gearing, M., Levey, A.I., Chin, L.S., Li, L., Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J. Biol. Chem. 281 (2006), 10816–10824.
36. Cimini, A., Moreno, S., D'Amelio, M., Cristiano, L., D'Angelo, B., Falone, S., Benedetti, E., Carrara, P., Fanelli, F., Cecconi, F., Amicarelli, F., Ceru, M.P., Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. J. Alzheimers Dis. 18 (2009), 935–952.
37. Conway, K.A., Rochet, J.C., Bieganski, R.M., Lansbury, P.T. Jr., Kinetic stabilization of the alpha-synuclein protofibril by a dopamine-alpha-synuclein adduct. Science 294 (2001), 1346–1349.
38. Cristovao, A.C., Guhathakurta, S., Bok, E., Je, G., Yoo, S.D., Choi, D.H., Kim, Y.S., NADPH oxidase 1 mediates alpha-synucleinopathy in Parkinson's disease. J. Neurosci. 32 (2012), 14465–14477.
39. Cruz, C.M., Rinna, A., Forman, H.J., Ventura, A.L., Persechini, P.M., Ojcius, D.M., ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J. Biol. Chem. 282 (2007), 2871–2879.
40. Datta, S.R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., Greenberg, M.E., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997), 231–241.
41. Dawson, T.M., Dawson, V.L., The role of parkin in familial and sporadic Parkinson's disease. Mov. Disord. 25:Suppl 1 (2010), S32–S39.
42. Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M.B., Holtzman, D.M., Zlokovic, B.V., apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J. Clin. Invest. 118 (2008), 4002–4013.
43. Di Pietro, V., Lazzarino, G., Amorini, A.M., Tavazzi, B., D'Urso, S., Longo, S., Vagnozzi, R., Signoretti, S., Clementi, E., Giardina, B., Belli, A., Neuroglobin expression and oxidant/antioxidant balance after graded traumatic brain injury in the rat. Free Radic. Biol. Med. 69 (2014), 258–264.
44. Dias, V., Junn, E., Mouradian, M.M., The role of oxidative stress in Parkinson's disease. J. Parkinsons Dis. 3 (2013), 461–491.
45. Dryanovski, D.I., Guzman, J.N., Xie, Z., Galteri, D.J., Volpicelli-Daley, L.A., Lee, V.M., Miller, R.J., Schumacker, P.T., Surmeier, D.J., Calcium entry and alpha-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neurons. J. Neurosci. 33 (2013), 10154–10164.
46. Dumont, M., Wille, E., Stack, C., Calingasan, N.Y., Beal, M.F., Lin, M.T., Reduction of oxidative stress amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J. 23 (2009), 2459–2466.
47. Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.Q., Bien-Ly, N., Puolivali, J., Scearce-Levie, K., Masliah, E., Mucke, L., Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 26 (2006), 5167–5179.
48. Evola, M., Hall, A., Wall, T., Young, A., Grammas, P., Oxidative stress impairs learning and memory in apoE knockout mice. Pharmacol. Biochem. Behav. 96 (2010), 181–186.
49. Ferreiro, E., Baldeiras, I., Ferreira, I.L., Costa, R.O., Rego, A.C., Pereira, C.F., Oliveira, C.R., Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. Int. J. Cell Biol., 2012, 2012, 735206.
50. Ferrer, I., Perez, E., Dalfo, E., Barrachina, M., Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neurosci. Lett. 415 (2007), 205–209.
51. Feuerstein, D., Backes, H., Gramer, M., Takagaki, M., Gabel, P., Kumagai, T., Graf, R., Regulation of cerebral metabolism during cortical spreading depression. J. Cereb. Blood Flow Metab., 2015.
52. Flynn, J.M., Melov, S., SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic. Biol. Med. 62 (2013), 4–12.
53. Foltynie, T., Brayne, C.E., Robbins, T.W., Barker, R.A., The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127 (2004), 550–560.
54. Fukui, M., Zhu, B.T., Mitochondrial superoxide dismutase SOD2 but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells. Free Radic. Biol. Med. 48 (2010), 821–830.
55. Fuxe, K., Manger, P., Genedani, S., Agnati, L., The nigrostriatal DA pathway and Parkinson's disease. J. Neural Transm. Suppl., 2006, 71–83.
56. Gao, C., Pang, H., Luo, X.G., Ren, Y., Shang, H., He, Z.Y., LRRK2 G2385R variant carriers of female Parkinson's disease are more susceptible to motor fluctuation. J. Neurol. 260 (2013), 2884–2889.
57. Gasser, T., Genetics of parkinson's disease. J. Neurol. 248 (2001), 833–840.
58. Gatz, M., Reynolds, C.A., Fratiglioni, L., Johansson, B., Mortimer, J.A., Berg, S., Fiske, A., Pedersen, N.L., Role of genes and environments for explaining Alzheimer disease. Arch. Gen. Psychiatry 63 (2006), 168–174.
59. Giaime, E., Yamaguchi, H., Gautier, C.A., Kitada, T., Shen, J., Loss of DJ-1 does not affect mitochondrial respiration but increases ROS production and mitochondrial permeability transition pore opening. PLoS One, 7, 2012, e40501.
60. Giraldo, E., Lloret, A., Fuchsberger, T., Vina, J., Abeta and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E. Redox Biol. 2 (2014), 873–877.
61. Girotto, S., Cendron, L., Bisaglia, M., Tessari, I., Mammi, S., Zanotti, G., Bubacco, L., DJ-1 is a copper chaperone acting on SOD1 activation. J. Biol. Chem. 289 (2014), 10887–10899.
62. Gloire, G., Charlier, E., Rahmouni, S., Volanti, C., Chariot, A., Erneux, C., Piette, J., Restoration of SHIP-1 activity in human leukemic cells modifies NF-kappaB activation pathway and cellular survival upon oxidative stress. Oncogene 25 (2006), 5485–5494.
63. Gloire, G., Legrand-Poels, S., Piette, J., NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72 (2006), 1493–1505.
64. Gomez del Rio, M.A., Sanchez-Reus, M.I., Iglesias, I., Pozo, M.A., Garcia-Arencibia, M., Fernandez-Ruiz, J., Garcia-Garcia, L., Delgado, M., Benedi, J., Neuroprotective properties of standardized extracts of hypericum perforatum on rotenone model of parkinson's disease. CNS Neurol. Disord. Drug Targets 12 (2013), 665–679.
65. Gorner, K., Holtorf, E., Odoy, S., Nuscher, B., Yamamoto, A., Regula, J.T., Beyer, K., Haass, C., Kahle, P.J., Differential effects of Parkinson's disease-associated mutations on stability and folding of DJ-1. J. Biol. Chem. 279 (2004), 6943–6951.
66. Greene, J.C., Whitworth, A.J., Kuo, I., Andrews, L.A., Feany, M.B., Pallanck, L.J., Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 4078–4083.
67. Guerra, A.N., Gavala, M.L., Chung, H.S., Bertics, P.J., Nucleotide receptor signalling and the generation of reactive oxygen species. Purinergic Signal. 3 (2007), 39–51.
68. Gunjima, K., Tomiyama, R., Takakura, K., Yamada, T., Hashida, K., Nakamura, Y., Konishi, T., Matsugo, S., Hori, O., 3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway. J. Cell. Biochem. 115 (2014), 151–160.
69. Guzman, J.N., Sanchez-Padilla, J., Wokosin, D., Kondapalli, J., Ilijic, E., Schumacker, P.T., Surmeier, D.J., Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468 (2010), 696–700.
70. Halliwell, B., Oxidative stress and neurodegeneration: where are we now?. J. Neurochem. 97 (2006), 1634–1658.
71. Hanger, D.P., Anderton, B.H., Noble, W., Tau phosphorylation: the therapeutic challenge for neurodegenerative disease. Trends Mol. Med. 15 (2009), 112–119.
72. Hao, L.Y., Giasson, B.I., Bonini, N.M., DJ-1 is critical for mitochondrial function and rescues PINK1 loss of function. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 9747–9752.
73. Hatano, T., Kubo, S., Sato, S., Hattori, N., Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem. 111 (2009), 1075–1093.
74. He, P., Ouyang, X., Zhou, S., Yin, W., Tang, C., Laudon, M., Tian, S., A novel melatonin agonist Neu-P11 facilitates memory performance and improves cognitive impairment in a rat model of Alzheimer' disease. Horm. Behav. 64 (2013), 1–7.
75. Henchcliffe, C., Beal, M.F., Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat. Clin. Pract. Neurol. 4 (2008), 600–609.
76. Hennis, M.R., Marvin, M.A., Taylor, C.M., Goldberg 2nd, M.S., Surprising behavioral and neurochemical enhancements in mice with combined mutations linked to Parkinson's disease. Neurobiol. Dis. 62 (2014), 113–123.
77. Heo, H.Y., Park, J.M., Kim, C.H., Han, B.S., Kim, K.S., Seol, W., LRRK2 enhances oxidative stress-induced neurotoxicity via its kinase activity. Exp. Cell Res. 316 (2010), 649–656.
78. Hernandes, M.S., Cafe-Mendes, C.C., Britto, L.R., NADPH oxidase and the degeneration of dopaminergic neurons in parkinsonian mice. Oxid. Med. Cell Longev., 2013, 2013, 157857.
79. Herscovitch, M., Comb, W., Ennis, T., Coleman, K., Yong, S., Armstead, B., Kalaitzidis, D., Chandani, S., Gilmore, T.D., Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. Biochem. Biophys. Res. Commun. 367 (2008), 103–108.
80. Hewinson, J., Mackenzie, A.B., P2X(7) receptor-mediated reactive oxygen and nitrogen species formation: from receptor to generators. Biochem. Soc. Trans. 35 (2007), 1168–1170.
81. Ho, P.W., Ho, J.W., Liu, H.F., So, D.H., Tse, Z.H., Chan, K.H., Ramsden, D.B., Ho, S.L., Mitochondrial neuronal uncoupling proteins: a target for potential disease-modification in Parkinson's disease. Transl. Neurodegener., 1, 2012, 3.
82. Holmstrom, K.M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J.M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 impacts cellular bioenergetics by controlling substrate availability for mitochondrial respiration. Biol. Open 2 (2013), 761–770.
83. Hracsko, Z., Baranyi, M., Csolle, C., Goloncser, F., Madarasz, E., Kittel, A., Sperlagh, B., Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol. Neurodegener., 6, 2011, 28.
84. Hwang, O., Role of oxidative stress in Parkinson's disease. Exp. Neurobiol. 22 (2013), 11–17.
85. Im, J.Y., Lee, K.W., Junn, E., Mouradian, M.M., DJ-1 protects against oxidative damage by regulating the thioredoxin/ASK1 complex. Neurosci. Res. 67 (2010), 203–208.
86. Im, J.Y., Lee, K.W., Woo, J.M., Junn, E., Mouradian, M.M., DJ-1 induces thioredoxin 1 expression through the Nrf2 pathway. Hum. Mol. Genet. 21 (2012), 3013–3024.
87. Iwai, K., Diverse ubiquitin signaling in NF-kappaB activation. Trends Cell Biol. 22 (2012), 355–364.
88. Jenner, P., Oxidative stress in Parkinson's disease. Ann. Neurol. 53:Suppl 3 (2003), S26–S36 discussion S36–S28.
89. Jiang, Q., Lee, C.Y., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T.M., Collins, J.L., Richardson, J.C., Smith, J.D., Comery, T.A., Riddell, D., Holtzman, D.M., Tontonoz, P., Landreth, G.E., ApoE promotes the proteolytic degradation of Abeta. Neuron 58 (2008), 681–693.
90. Jiang, T., Hoekstra, J., Heng, X., Kang, W., Ding, J., Liu, J., Chen, S., Zhang, J., P2X7 receptor is critical in alpha-synuclein?mediated microglial NADPH oxidase activation. Neurobiol. Aging 36 (2015), 2304–2318.
91. Jin, L.W., Microglia in Alzheimer's disease. Int. J. Alzheimers Dis., 2012, 2012, 598371.
92. Jolivalt, C., Leininger-Muller, B., Bertrand, P., Herber, R., Christen, Y., Siest, G., Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids. Free Radic. Biol. Med. 28 (2000), 129–140.
93. Junn, E., Jang, W.H., Zhao, X., Jeong, B.S., Mouradian, M.M., Mitochondrial localization of DJ-1 leads to enhanced neuroprotection. J. Neurosci. Res. 87 (2009), 123–129.
94. Kang, W.Y., Yang, Q., Jiang, X.F., Chen, W., Zhang, L.Y., Wang, X.Y., Zhang, L.N., Quinn, T.J., Liu, J., Chen, S.D., Salivary DJ-1 could be an indicator of Parkinson's disease progression. Front. Aging Neurosci., 6, 2014, 102.
95. Kayed, R., Tau oligomers as potential drug target for Alzheimer disease (AD) treatment. de la Monte, S., (eds.) Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets, 2011, In Tech, Rijeka, 635–646.
96. Kemppainen, S., Lindholm, P., Galli, E., Lahtinen, H.M., Koivisto, H., Hamalainen, E., Saarma, M., Tanila, H., Cerebral dopamine neurotrophic factor improves long-term memory in APP/PS1 transgenic mice modeling Alzheimer's disease as well as in wild-type mice. Behav. Brain Res. 291 (2015), 1–11.
97. Khurana, N., Gajbhiye, A., Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease. Neurotoxicology 39 (2013), 57–64.
98. Kim, M., Jiang, L.H., Wilson, H.L., North, R.A., Surprenant, A., Proteomic and functional evidence for a P2X7 receptor signalling complex. EMBO J. 20 (2001), 6347–6358.
99. Klugman, A., Naughton, D.P., Isaac, M., Shah, I., Petroczi, A., Tabet, N., Antioxidant enzymatic activities in Alzheimer's disease: the relationship to acetylcholinesterase inhibitors. J. Alzheimers Dis. 30 (2012), 467–474.
100. Koriyama, Y., Nakayama, Y., Matsugo, S., Kato, S., Protective effect of lipoic acid against oxidative stress is mediated by Keap1/Nrf2-dependent heme oxygenase-1 induction in the RGC-5 cellline. Brain Res. 1499 (2013), 145–157.
101. Kovac, S., Angelova, P.R., Holmstrom, K.M., Zhang, Y., Dinkova-Kostova, A.T., Abramov, A.Y., Nrf2 regulates ROS production by mitochondria and NADPH oxidase. Biochim. Biophys. Acta 1850 (2015), 794–801.
102. Krugel, U., Kittner, H., Franke, H., Illes, P., Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse 47 (2003), 134–142.
103. Kubo, S., Hatano, T., Takanashi, M., Hattori, N., Can parkin be a target for future treatment of Parkinson's disease?. Expert Opin. Ther. Targets 17 (2013), 1133–1144.
104. Kwak, Y.D., Wang, R., Li, J.J., Zhang, Y.W., Xu, H., Liao, F.F., Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol. Neurodegener., 6, 2011, 17.
105. Kwon, S.H., Ma, S.X., Hong, S.I., Kim, S.Y., Lee, S.Y., Jang, C.G., Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells. J. Ethnopharmacol. 152 (2014), 173–182.
106. Lakshminarasimhan, M., Maldonado, M.T., Zhou, W., Fink, A.L., Wilson, M.A., Structural impact of three Parkinsonism-associated missense mutations on human DJ-1. Biochemistry 47 (2008), 1381–1392.
107. Lalo, U., Pankratov, Y., Wichert, S.P., Rossner, M.J., North, R.A., Kirchhoff, F., Verkhratsky, A., P2 × 1 and P2 × 5 subunits form the functional P2X receptor in mouse cortical astrocytes. J. Neurosci. 28 (2008), 5473–5480.
108. Lalo, U., Pankratov, Y., Parpura, V., Verkhratsky, A., Ionotropic receptors in neuronal-astroglial signalling: what is the role of excitable molecules in non-excitable cells. Biochim. Biophys. Acta 1813 (2011), 992–1002.
109. Larsen, N.J., Ambrosi, G., Mullett, S.J., Berman, S.B., Hinkle, D.A., DJ-1 knock-down impairs astrocyte mitochondrial function. Neuroscience 196 (2011), 251–264.
110. Lee, H.N., Surh, Y.J., Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. Biochem. Pharmacol. 86 (2013), 759–769.
111. Lee, M., Jantaratnotai, N., McGeer, E., McLarnon, J.G., McGeer, P.L., Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. Brain Res. 1369 (2011), 21–35.
112. Lee, Y.K., Choi, I.S., Ban, J.O., Lee, H.J., Lee, U.S., Han, S.B., Jung, J.K., Kim, Y.H., Kim, K.H., Oh, K.W., Hong, J.T., 4-O-methylhonokiol attenuated beta-amyloid-induced memory impairment through reduction of oxidative damages via inactivation of p38 MAP kinase. J. Nutr. Biochem. 22 (2011), 476–486.
113. Lee, D.H., Gold, R., Linker, R.A., Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int. J. Mol. Sci. 13 (2012), 11783–11803.
114. Lee, H.P., Pancholi, N., Esposito, L., Previll, L.A., Wang, X., Zhu, X., Smith, M.A., Lee, H.G., Early induction of oxidative stress in mouse model of Alzheimer disease with reduced mitochondrial superoxide dismutase activity. PLoS One, 7, 2012, e28033.
115. Lee, S., Tong, M., Hang, S., Deochand, C., de la Monte, S., CSF and brain indices of insulin resistance, oxidative stress and neuro-Inflammation in early versus late alzheimer's disease. J. Alzheimers Dis. Parkinsonism, 3, 2013, 128.
116. Leoni, V., The effect of apolipoprotein E (ApoE) genotype on biomarkers of amyloidogenesis: tau pathology and neurodegeneration in Alzheimer's disease. Clin. Chem. Lab. Med. 49 (2011), 375–383.
117. Li, Q., Engelhardt, J.F., Interleukin-1beta induction of NFkappaB is partially regulated by H2O2-mediated activation of NFkappaB-inducing kinase. J. Biol. Chem. 281 (2006), 1495–1505.
118. Li, C., Ting, Z., Qin, X., Ying, W., Li, B., Guo Qiang, L., Jian Fang, M., Jing, Z., Jian Qing, D., Sheng Di, C., The prevalence of LRRK2 Gly2385Arg variant in Chinese Han population with Parkinson's disease. Mov. Disord. 22 (2007), 2439–2443.
119. Li, T., Yang, D., Sushchky, S., Liu, Z., Smith, W.W., Models for LRRK2-Linked parkinsonism. Parkinsons Dis., 2011, 2011, 942412.
120. Li, W., Jiang, H., Song, N., Xie, J., Oxidative stress partially contributes to iron-induced alpha-synuclein aggregation in SK-N-SH cells. Neurotox. Res. 19 (2011), 435–442.
121. Li, D.Z., Zhang, Q.X., Dong, X.X., Li, H.D., Ma, X., Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells. J. Bone Miner. Metab. 32 (2014), 494–504.
122. Liao, G., Zhang, M., Harhaj, E.W., Sun, S.C., Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J. Biol. Chem. 279 (2004), 26243–26250.
123. Lim, J.H., Kim, K.M., Kim, S.W., Hwang, O., Choi, H.J., Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: novel cytoprotective mechanism against oxidative damage. Pharmacol. Res. 57 (2008), 325–331.
124. Lin, M.T., Beal, M.F., Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006), 787–795.
125. Lippa, C.F., Saunders, A.M., Smith, T.W., Swearer, J.M., Drachman, D.A., Ghetti, B., Nee, L., Pulaski-Salo, D., Dickson, D., Robitaille, Y., Bergeron, C., Crain, B., Benson, M.D., Farlow, M., Hyman, B.T., George-Hyslop, S.P., Roses, A.D., Pollen, D.A., Familial and sporadic Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 46 (1996), 406–412.
126. Liu, M.H., Yuan, C., He, J., Tan, T.P., Wu, S.J., Fu, H.Y., Liu, J., Yu, S., Chen, Y.D., Le, Q.F., Tian, W., Hu, H.J., Zhang, Y., Lin, X.L., Resveratrol protects PC12 cells from high glucose-induced neurotoxicity via PI3K/Akt/FoxO3a pathway. Cell. Mol. Neurobiol. 35 (2015), 513–522.
127. Lloret, A., Badia, M.C., Mora, N.J., Pallardo, F.V., Alonso, M.D., Vina, J., Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental. J. Alzheimers Dis. 17 (2009), 143–149.
128. Lloret, A., Badia, M.C., Giraldo, E., Ermak, G., Alonso, M.D., Pallardo, F.V., Davies, K.J., Vina, J., Amyloid-beta toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease. J. Alzheimers Dis. 27 (2011), 701–709.
129. Lou, H., Jing, X., Wei, X., Shi, H., Ren, D., Zhang, X., Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway. Neuropharmacology 79 (2014), 380–388.
130. Ludtmann, M.H., Angelova, P.R., Zhang, Y., Abramov, A.Y., Dinkova-Kostova, A.T., Nrf2 affects the efficiency of mitochondrial fatty acid oxidation. Biochem. J. 457 (2014), 415–424.
131. Lull, M.E., Block, M.L., Microglial activation and chronic neurodegeneration. Neurotherapeutics 7 (2010), 354–365.
132. Maetzler, W., Berg, D., Schalamberidze, N., Melms, A., Schott, K., Mueller, J.C., Liaw, L., Gasser, T., Nitsch, C., Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model. Neurobiol. Dis. 25 (2007), 473–482.
133. Maita, C., Maita, H., Iguchi-Ariga, S.M., Ariga, H., Monomer DJ-1 and its N-terminal sequence are necessary for mitochondrial localization of DJ-1 mutants. PLoS One, 8, 2013, e54087.
134. Malgieri, G., Eliezer, D., Structural effects of Parkinson's disease linked DJ-1 mutations. Protein Sci. 17 (2008), 855–868.
135. Mancuso, M., Coppede, F., Murri, L., Siciliano, G., Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid. Redox Signal. 9 (2007), 1631–1646.
136. Mancuso, M., Orsucci, D., LoGerfo, A., Calsolaro, V., Siciliano, G., Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. Adv. Exp. Med. Biol. 685 (2010), 34–44.
137. Mansouri, M.T., Farbood, Y., Sameri, M.J., Sarkaki, A., Naghizadeh, B., Rafeirad, M., Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. Food Chem. 138 (2013), 1028–1033.
138. Marcellino, D., Suarez-Boomgaard, D., Sanchez-Reina, M.D., Aguirre, J.A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L.F., Fuxe, K., Rivera, A., On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079. J. Neural Transm. 117 (2010), 681–687.
139. Martel-Gallegos, G., Casas-Pruneda, G., Ortega-Ortega, F., Sanchez-Armass, S., Olivares-Reyes, J.A., Diebold, B., Perez-Cornejo, P., Arreola, J., Oxidative stress induced by P2X7 receptor stimulation in murine macrophages is mediated by c-Src/Pyk2 and ERK1/2. Biochim. Biophys. Acta 1830 (2013), 4650–4659.
140. Martinez-Vicente, M., Talloczy, Z., Kaushik, S., Massey, A.C., Mazzulli, J., Mosharov, E.V., Hodara, R., Fredenburg, R., Wu, D.C., Follenzi, A., Dauer, W., Przedborski, S., Ischiropoulos, H., Lansbury, P.T., Sulzer, D., Cuervo, A.M., Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J. Clin. Invest. 118 (2008), 777–788.
141. Melief, E.J., Cudaback, E., Jorstad, N.L., Sherfield, E., Postupna, N., Wilson, A., Darvas, M., Montine, K.S., Keene, C.D., Montine, T.J., Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer's disease. J. Neurosci. Res. 93 (2015), 1413–1422.
142. Milani, P., Ambrosi, G., Gammoh, O., Blandini, F., Cereda, C., SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration. Oxid. Med. Cell Longev., 2013, 2013, 836760.
143. Miller, E.R., Pastor-Barriuso, 3rd, Dalal, R., Riemersma, D., Appel, R.A., Guallar, L.J., Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann. Intern. Med. 142 (2005), 37–46.
144. Mirelman, A., Heman, T., Yasinovsky, K., Thaler, A., Gurevich, T., Marder, K., Bressman, S., Bar-Shira, A., Orr-Urtreger, A., Giladi, N., Hausdorff, J.M., Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation. Mov. Disord. 28 (2013), 1683–1690.
145. Mondragon-Rodriguez, S., Basurto-Islas, G., Santa-Maria, I., Mena, R., Binder, L.I., Avila, J., Smith, M.A., Perry, G., Garcia-Sierra, F., Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. Int. J. Exp. Pathol. 89 (2008), 81–90.
146. Mondragon-Rodriguez, S., Basurto-Islas, G., Lee, H.G., Perry, G., Zhu, X., Castellani, R.J., Smith, M.A., Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Rev. Neurother. 10 (2010), 683–691.
147. Mondragon-Rodriguez, S., Perry, G., Zhu, X., Boehm, J., Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy. Int. J. Alzheimers Dis., 2012, 2012, 630182.
148. Mondragon-Rodriguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., Boehm, J., Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. J. Biol. Chem. 287 (2012), 32040–32053.
149. Moore, D.J., Zhang, L., Dawson, T.M., Dawson, V.L., A missense mutation (L166P) in DJ-1 linked to familial Parkinson's disease, confers reduced protein stability and impairs homo-oligomerization. J. Neurochem. 87 (2003), 1558–1567.
150. Morgan, M.J., Liu, Z.G., Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res. 21 (2011), 103–115.
151. Morroni, F., Tarozzi, A., Sita, G., Bolondi, C., Zolezzi Moraga, J.M., Cantelli-Forti, G., Hrelia, P., Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease. Neurotoxicology 36 (2013), 63–71.
152. Muller, S.K., Bender, A., Laub, C., Hogen, T., Schlaudraff, F., Liss, B., Klopstock, T., Elstner, M., Lewy body pathology is associated with mitochondrial DNA damage in Parkinson's disease. Neurobiol. Aging 34 (2013), 2231–2233.
153. Mullett, S.J., Hinkle, D.A., DJ-1 deficiency in astrocytes selectively enhances mitochondrial Complex I inhibitor-induced neurotoxicity. J. Neurochem. 117 (2011), 375–387.
154. Nagasawa, K., Escartin, C., Swanson, R.A., Astrocyte cultures exhibit P2X7 receptor channel opening in the absence of exogenous ligands. Glia 57 (2009), 622–633.
155. Nakajima, S., Kitamura, M., Bidirectional regulation of NF-kappaB by reactive oxygen species: a role of unfolded protein response. Free Radic. Biol. Med. 65 (2013), 162–174.
156. Nalls, M.A., Plagnol, V., Hernandez, D.G., Sharma, M., Sheerin, U.M., Saad, M., Simon-Sanchez, J., Schulte, C., Lesage, S., Sveinbjornsdottir, S., Stefansson, K., Martinez, M., Hardy, J., Heutink, P., Brice, A., Gasser, T., Singleton, A.B., Wood, N.W., Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377 (2011), 641–649.
157. Noguchi, T., Ishii, K., Fukutomi, H., Naguro, I., Matsuzawa, A., Takeda, K., Ichijo, H., Requirement of reactive oxygen species-dependent activation of ASK1-p38 MAPK pathway for extracellular ATP-induced apoptosis in macrophage. J. Biol. Chem. 283 (2008), 7657–7665.
158. Norris, E.H., Giasson, B.I., Ischiropoulos, H., Lee, V.M., Effects of oxidative and nitrative challenges on alpha-synuclein fibrillogenesis involve distinct mechanisms of protein modifications. J. Biol. Chem. 278 (2003), 27230–27240.
159. Opazo, C., Huang, X., Cherny, R.A., Moir, R.D., Roher, A.E., White, A.R., Cappai, R., Masters, C.L., Tanzi, R.E., Inestrosa, N.C., Bush, A.I., Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J. Biol. Chem. 277 (2002), 40302–40308.
160. Orellano, E.A., Rivera, O.J., Chevres, M., Chorna, N.E., Gonzalez, F.A., Inhibition of neuronal cell death after retinoic acid-induced down-regulation of P2X7 nucleotide receptor expression. Mol. Cell. Biochem. 337 (2010), 83–99.
161. Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., Stefanescu, C., Changes of some oxidative stress markers in the serum of patients with mild cognitive impairment and Alzheimer's disease. Neurosci. Lett. 469 (2010), 6–10.
162. Padurariu, M., Ciobica, A., Lefter, R., Serban, I.L., Stefanescu, C., Chirita, R., The oxidative stress hypothesis in Alzheimer's disease. Psychiatr. Danub. 25 (2013), 401–409.
163. Paisan-Ruiz, C., Jain, S., Evans, E.W., Gilks, W.P., Simon, J., van der Brug, M., Lopez de Munain, A., Aparicio, S., Gil, A.M., Khan, N., Johnson, J., Martinez, J.R., Nicholl, D., Carrera, I.M., Pena, A.S., de Silva, R., Lees, A., Marti-Masso, J.F., Perez-Tur, J., Wood, N.W., Singleton, A.B., Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004), 595–600.
164. Palacino, J.J., Sagi, D., Goldberg, M.S., Krauss, S., Motz, C., Wacker, M., Klose, J., Shen, J., Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279 (2004), 18614–18622.
165. Pan, J., Li, H., Ma, J.F., Tan, Y.Y., Xiao, Q., Ding, J.Q., Chen, S.D., Curcumin inhibition of JNKs prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease through suppressing mitochondria dysfunction. Transl. Neurodegener., 1, 2012, 16.
166. Parker, W.D. Jr., Parks, J.K., Swerdlow, R.H., Complex I deficiency in Parkinson's disease frontal cortex. Brain Res. 1189 (2008), 215–218.
167. Parthasarathy, S., Yoo, B., McElheny, D., Tay, W., Ishii, Y., Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid beta-fibrils in a redox cycle. J. Biol. Chem. 289 (2014), 9998–10010.
168. Parvathenani, L.K., Tertyshnikova, S., Greco, C.R., Roberts, S.B., Robertson, B., Posmantur, R., P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278 (2003), 13309–13317.
169. Perfeito, R., Cunha-Oliveira, T., Rego, A.C., Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. Free Radic. Biol. Med. 62 (2013), 186–201.
170. Pfeiffer, Z.A., Guerra, A.N., Hill, L.M., Gavala, M.L., Prabhu, U., Aga, M., Hall, D.J., Bertics, P.J., Nucleotide receptor signaling in murine macrophages is linked to reactive oxygen species generation. Free Radic. Biol. Med. 42 (2007), 1506–1516.
171. Pieri, C., Marra, M., Moroni, F., Recchioni, R., Marcheselli, F., Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55 (1994), PL271–276.
172. Raichur, A., Vali, S., Gorin, F., Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson's disease. Neuroscience 142 (2006), 859–870.
173. Reddy, P.H., Beal, M.F., Amyloid beta: mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14 (2008), 45–53.
174. Reitz, C., Mayeux, R., Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia. J. Alzheimers Dis. 19 (2010), 229–251.
175. Resende, R., Moreira, P.I., Proenca, T., Deshpande, A., Busciglio, J., Pereira, C., Oliveira, C.R., Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic. Biol. Med. 44 (2008), 2051–2057.
176. Reynaert, N.L., van der Vliet, A., Guala, A.S., McGovern, T., Hristova, M., Pantano, C., Heintz, N.H., Heim, J., Ho, Y.S., Matthews, D.E., Wouters, E.F., Janssen-Heininger, Y.M., Dynamic redox control of NF-kappaB through glutaredoxin-regulated S-glutathionylation of inhibitory kappaB kinase beta. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 13086–13091.
177. Ringman, J.M., Cole, G., Teng, E., Badmaev, V., Bardens, J., Frautschy, S., Rosario, E., Fein, J., Porter, V., Vanek, Z., P4-344: oral curcumin for the treatment of mild-to-moderate Alzheimer's disease: tolerability and clinical and biomarker efficacy results of a placebo-controlled 24-week study. Alzheimer Dement., 4, 2008, T774.
178. Roth, J.A., Eichhorn, M., Down-regulation of LRRK2 in control and DAT transfected HEK cells increases manganese-induced oxidative stress and cell toxicity. Neurotoxicology 37 (2013), 100–107.
179. Saez, E.T., Pehar, M., Vargas, M.R., Barbeito, L., Maccioni, R.B., Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75NTR-dependent tau hyperphosphorylation in cultured hippocampal neurons. J. Neurosci. Res. 84 (2006), 1098–1106.
180. Safarian, F., Khallaghi, B., Ahmadiani, A., Dargahi, L., Activation of S1P(1) receptor regulates PI3 K/Akt/FoxO3a pathway in response to oxidative stress in PC12 cells. J. Mol. Neurosci. 56 (2015), 177–187.
181. Sanders, L.H., Greenamyre, J.T., Oxidative damage to macromolecules in human Parkinson disease and the rotenone model. Free Radic. Biol. Med. 62 (2013), 111–120.
182. Sano, M., Ernesto, C., Thomas, R.G., Klauber, M.R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C.W., Pfeiffer, E., Schneider, L.S., Thal, L.J., A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease: the Alzheimer's Disease Cooperative Study. N. Engl. J. Med. 336 (1997), 1216–1222.
183. Santpere, G., Ferrer, I., LRRK2 and neurodegeneration. Acta Neuropathol. 117 (2009), 227–246.
184. Satoh, T., McKercher, S.R., Lipton, S.A., Reprint of: nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. Free Radic. Biol. Med. 66 (2014), 45–57.
185. Schiesling, C., Kieper, N., Seidel, K., Kruger, R., Review: familial Parkinson's disease-genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease. Neuropathol. Appl. Neurobiol. 34 (2008), 255–271.
186. Shen, C., Chen, Y., Liu, H., Zhang, K., Zhang, T., Lin, A., Jing, N., Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J. Biol. Chem. 283 (2008), 7721–17730.
187. Shukla, V., Mishra, S.K., Pant, H.C., Oxidative stress in neurodegeneration. Adv. Pharmacol. Sci., 2011, 2011, 572634.
188. Sinem, F., Dildar, K., Gokhan, E., Melda, B., Orhan, Y., Filiz, M., The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy. Curr. Alzheimer Res. 7 (2010), 463–469.
189. Singh, P.P., Singh, M., Mastana, S.S., Genetic variation of apolipoproteins in North Indians. Hum. Biol. 74 (2002), 673–682.
190. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M.R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., Gwinn-Hardy, K., alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 2003, 841.
191. Sorbi, S., Nacmias, B., Forleo, P., Latorraca, S., Gobbini, I., Bracco, L., Piacentini, S., Amaducci, L., ApoE allele frequencies in Italian sporadic and familial Alzheimer's disease. Neurosci. Lett. 177 (1994), 100–102.
192. Sorce, S., Krause, K.H., NOX enzymes in the central nervous system: from signaling to disease. Antioxid. Redox Signal. 11 (2009), 2481–2504.
193. Su, X., Maguire-Zeiss, K.A., Giuliano, R., Prifti, L., Venkatesh, K., Federoff, H.J., Synuclein activates microglia in a model of Parkinson's disease. Neurobiol. Aging 29 (2008), 1690–1701.
194. Subramaniam, S.R., Chesselet, M.F., Mitochondrial dysfunction and oxidative stress in Parkinson's disease. Prog. Neurobiol. 106–107 (2013), 17–32.
195. Suh, S.W., Jensen, K.B., Jensen, M.S., Silva, D.S., Kesslak, P.J., Danscher, G., Frederickson, C.J., Histochemically-reactive zinc in amyloid plaques angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 852 (2000), 274–278.
196. Tabet, N., Mantle, D., Walker, Z., Orrell, M., Endogenous antioxidant activities in relation to concurrent vitamins A C, and E intake in dementia. Int. Psychogeriatr. 14 (2002), 7–15.
197. Tai, L.M., Koster, K.P., Luo, J., Lee, S.H., Wang, Y.T., Collins, N.C., Ben Aissa, M., Thatcher, G.R., LaDu, M.J., Amyloid-beta pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. J. Biol. Chem. 289 (2014), 30538–30555.
198. Taira, T., Saito, Y., Niki, T., Iguchi-Ariga, S.M., Takahashi, K., Ariga, H., DJ-1 has a role in antioxidative stress to prevent cell death. EMBO Rep. 5 (2004), 213–218.
199. Takahashi, R., Kawamata, J., Takeuchi, H., Pathogenesis of sporadic Parkinson's disease: contribution of genetic and environmental risk factors. Rinsho Shinkeigaku 49 (2009), 885–887.
200. Takenouchi, T., Sekiyama, K., Sekigawa, A., Fujita, M., Waragai, M., Sugama, S., Iwamaru, Y., Kitani, H., Hashimoto, M., P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp. (Warsz.) 58 (2010), 91–96.
201. Tiong, C.X., Lu, M., Bian, J.S., Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway. Br. J. Pharmacol. 161 (2010), 467–480.
202. Tong, Y., Pisani, A., Martella, G., Karouani, M., Yamaguchi, H., Pothos, E.N., Shen, J., R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 14622–14627.
203. Trexler, A.J., Rhoades, E., N-Terminal acetylation is critical for forming alpha-helical oligomer of alpha-synuclein. Protein Sci. 21 (2012), 601–605.
204. Van Den Eeden, S.K., Tanner, C.M., Bernstein, A.L., Fross, R.D., Leimpeter, A., Bloch, D.A., Nelson, L.M., Incidence of Parkinson's disease: variation by age gender, and race/ethnicity. Am. J. Epidemiol. 157 (2003), 1015–1022.
205. Vibha, D., Sureshbabu, S., Shukla, G., Goyal, V., Srivastava, A.K., Singh, S., Behari, M., Differences between familial and sporadic Parkinson's disease. Parkinsonism Relat. Disord. 16 (2010), 486–487.
206. Waak, J., Weber, S.S., Gorner, K., Schall, C., Ichijo, H., Stehle, T., Kahle, P.J., Oxidizable residues mediating protein stability and cytoprotective interaction of DJ-1 with apoptosis signal-regulating kinase 1. J. Biol. Chem. 284 (2009), 14245–14257.
207. Waak, J., Weber, S.S., Waldenmaier, A., Gorner, K., Alunni-Fabbroni, M., Schell, H., Vogt-Weisenhorn, D., Pham, T.T., Reumers, V., Baekelandt, V., Wurst, W., Kahle, P.J., Regulation of astrocyte inflammatory responses by the Parkinson's disease-associated gene DJ-1. FASEB J. 23 (2009), 2478–2489.
208. Wang, X.J., Zhang, S., Yan, Z.Q., Zhao, Y.X., Zhou, H.Y., Wang, Y., Lu, G.Q., Zhang, J.D., Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging superoxide, NADPH oxidase, and p38 MAPK. Free Radic. Biol. Med. 50 (2011), 1094–1106.
209. Wang, Z., Liu, J., Chen, S., Wang, Y., Cao, L., Zhang, Y., Kang, W., Li, H., Gui, Y., Ding, J., DJ-1 modulates the expression of Cu/Zn-superoxide dismutase-1 through the Erk1/2-Elk1 pathway in neuroprotection. Ann. Neurol. 70 (2011), 591–599.
210. Wang, C., Cai, Y., Zheng, Z., Tang, B.S., Xu, Y., Wang, T., Ma, J., Chen, S.D., Langston, J.W., Tanner, C.M., Chan, P., Penetrance of LRRK2 G2385R and R1628P is modified by common PD-associated genetic variants. Parkinsonism Relat. Disord. 18 (2012), 958–963.
211. Wang, Y., Yang, J., Yi, J., Redox sensing by proteins: oxidative modifications on cysteines and the consequent events. Antioxid. Redox Signal. 16 (2012), 649–657.
212. Wang, Y., Wang, G.Z., Rabinovitch, P.S., Tabas, I., Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-kappaB-mediated inflammation in macrophages. Circ. Res. 114 (2014), 421–433.
213. Wautier, M.P., Chappey, O., Corda, S., Stern, D.M., Schmidt, A.M., Wautier, J.L., Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am. J. Physiol. Endocrinol. Metab. 280 (2001), E685–694.
214. Wei, L., Ding, L., Mo, M.S., Lei, M., Zhang, L., Chen, K., Xu, P., Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function. Transl. Neurodegener., 4, 2015, 11.
215. Wider, C., Dickson, D.W., Wszolek, Z.K., Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Neurodegener. Dis. 7 (2010), 175–179.
216. Wilson, M.A., The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid. Redox Signal. 15 (2011), 111–122.
217. Wu, M., Bian, Q., Liu, Y., Fernandes, A.F., Taylor, A., Pereira, P., Shang, F., Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome. Free Radic. Biol. Med. 46 (2009), 62–69.
218. Wu, K.C., Cui, J.Y., Klaassen, C.D., Beneficial role of Nrf2 in regulating NADPH generation and consumption. Toxicol. Sci. 123 (2011), 590–600.
219. Xie, H., Hou, S., Jiang, J., Sekutowicz, M., Kelly, J., Bacskai, B.J., Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 7904–7909.
220. Xiong, L., Zhao, P., Guo, Z., Zhang, J., Li, D., Mao, C., Alpha-synuclein gene structure, evolution, and protein aggregation. Neural Regen. Res., 2010, 5.
221. Yamashita, S., Mori, A., Kimura, E., Mita, S., Maeda, Y., Hirano, T., Uchino, M., DJ-1 forms complexes with mutant SOD1 and ameliorates its toxicity. J. Neurochem. 113 (2010), 860–870.
222. Yan, S.D., Bierhaus, A., Nawroth, P.P., Stern, D.M., RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?. J. Alzheimers Dis. 16 (2009), 833–843.
223. Yanagida, T., Tsushima, J., Kitamura, Y., Yanagisawa, D., Takata, K., Shibaike, T., Yamamoto, A., Taniguchi, T., Yasui, H., Taira, T., Morikawa, S., Inubushi, T., Tooyama, I., Ariga, H., Oxidative stress induction of DJ-1 protein in reactive astrocytes scavenges free radicals and reduces cell injury. Oxid. Med. Cell Longev. 2 (2009), 36–42.
224. Yang, Y., Gehrke, S., Haque, M.E., Imai, Y., Kosek, J., Yang, L., Beal, M.F., Nishimura, I., Wakamatsu, K., Ito, S., Takahashi, R., Lu, B., Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 13670–13675.
225. Yang, H., Zhou, H.Y., Li, B., Niu, G.Z., Chen, S.D., Downregulation of parkin damages antioxidant defenses and enhances proteasome inhibition-induced toxicity in PC12 cells. J. Neuroimmune Pharmacol. 2 (2007), 276–283.
226. Yang, D., Li, T., Liu, Z., Arbez, N., Yan, J., Moran, T.H., Ross, C.A., Smith, W.W., LRRK2 kinase activity mediates toxic interactions between genetic mutation and oxidative stress in a Drosophila model: suppression by curcumin. Neurobiol. Dis. 47 (2012), 385–392.
227. Yang, S., Xia, C., Li, S., Du, L., Zhang, L., Hu, Y., Mitochondrial dysfunction driven by the LRRK2-mediated pathway is associated with loss of Purkinje cells and motor coordination deficits in diabetic rat model. Cell. Death. Dis., 5, 2014, e1217.
228. Yasuda, T., Kaji, Y., Agatsuma, T., Niki, T., Arisawa, M., Shuto, S., Ariga, H., Iguchi-Ariga, S.M., DJ-1 cooperates with PYCR1 in cell protection against oxidative stress. Biochem. Biophys. Res. Commun. 436 (2013), 289–294.
229. Zeldich, E., Chen, C.D., Colvin, T.A., Bove-Fenderson, E.A., Liang, J., Tucker Zhou, T.B., Harris, D.A., Abraham, C.R., The neuroprotective effect of Klotho is mediated via regulation of members of the redox system. J. Biol. Chem. 289 (2014), 24700–24715.
230. Zhang, W., Wang, T., Pei, Z., Miller, D.S., Wu, X., Block, M.L., Wilson, B., Zhou, Y., Hong, J.S., Zhang, J., Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. FASEB J. 19 (2005), 533–542.
231. Zhang, W., Dallas, S., Zhang, D., Guo, J.P., Pang, H., Wilson, B., Miller, D.S., Chen, B., McGeer, P.L., Hong, J.S., Zhang, J., Microglial PHOX and Mac-1 are essential to the enhanced dopaminergic neurodegeneration elicited by A30P and A53T mutant alpha-synuclein. Glia 55 (2007), 1178–1188.
232. Zhang, J., Malik, A., Choi, H.B., Ko, R.W., Dissing-Olesen, L., MacVicar, B.A., Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 82 (2014), 195–207.
233. Zheng, K., Dai, X., Xiao, N., Wu, X., Wei, Z., Fang, W., Zhu, Y., Zhang, J., Chen, X., Curcumin ameliorates memory decline via inhibiting BACE1 expression and beta-Amyloid pathology in 5xFAD transgenic mice. Mol. Neurobiol., 2016.
234. Zhou, H.Y., Tan, Y.Y., Wang, Z.Q., Wang, G., Lu, G.Q., Chen, S.D., Proteasome inhibitor lactacystin induces cholinergic degeneration. Can. J. Neurol. Sci. 37 (2010), 229–234.
235. Zhou, W.W., Lu, S., Su, Y.J., Xue, D., Yu, X.L., Wang, S.W., Zhang, H., Xu, P.X., Xie, X.X., Liu, R.T., Decreasing oxidative stress and neuroinflammation with a multifunctional peptide rescues memory deficits in mice with Alzheimer disease. Free Radic. Biol. Med. 74 (2014), 50–63.
236. Zhu, Y., Hoell, P., Ahlemeyer, B., Sure, U., Bertalanffy, H., Krieglstein, J., Implication of PTEN in production of reactive oxygen species and neuronal death in vitro models of stroke and Parkinson's disease. Neurochem. Int. 50 (2007), 507–516.